Inder Kaul

27 papers receiving 599 citations

Inder Kaul's Hit Papers

Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia 2024 · 84 citations
840+1+2Years since publication4080120

Peers

Inder Kaul
Comparison fields: 5 of 73
  • Biological Psychiatry 109
  • Behavioral Neuroscience 61
  • Psychiatry and Mental health 160
  • Cellular and Molecular Neuroscience 119
  • Pharmacology 102
Replace Alma Mihaljević Peleš with:
Alma Mihaljević Peleš Croatia
Graziela Amboni Brazil
Alyson Nakamura United States
Leif Hommers Germany
Sara Guevara United States
Matthew J. Lennon Australia
Michael D. Kritzer United States
Chengyu Wang China
Pei‐Shen Ho Taiwan
Qinyu Lv China
Inder Kaul relative to Alma Mihaljević Peleš Croatia Alma Mihaljević Peleš's profile →
Citations per field
00.5×10×14.7×
Alma Mihaljević Peleš · 1×
Citations per year

Countries citing papers authored by Inder Kaul

Since Specialization
Citations

This map shows the geographic impact of Inder Kaul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inder Kaul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inder Kaul more than expected).

Fields of papers citing papers by Inder Kaul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inder Kaul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inder Kaul. The network helps show where Inder Kaul may publish in the future.

Co-authors

The 25 scholars most cited alongside Inder Kaul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Inder Kaul Line = papers co-authored together Inder Kaul links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2019173
2
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
Hit paper breakdown →
2023123
3
Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia
Hit paper breakdown →
202484
4 201949
5 202430
6 201329
7 201325
8
Serum sialic acid levels in healthy individuals.
199022
9 202019
10 202416
11 20238
12 20126
13 20255
14 20254
15 20253
16 20262
17 20242
18 20242
19 20252
20 20172

About Inder Kaul

Inder Kaul is a scholar working on Psychiatry and Mental health, Molecular Biology, Epidemiology, Hematology and Neurology, having authored 32 papers that have together received 614 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (9 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Sepsis Diagnosis and Treatment (3 papers), Bipolar Disorder and Treatment (2 papers), Receptor Mechanisms and Signaling (2 papers), Neuroscience and Neural Engineering (1 paper), Traumatic Brain Injury and Neurovascular Disturbances (1 paper) and Neurological disorders and treatments (1 paper). The work is most often cited by research in Biological Psychiatry (109 citations), Behavioral Neuroscience (61 citations), Psychiatry and Mental health (160 citations), Cellular and Molecular Neuroscience (119 citations) and Pharmacology (102 citations). Inder Kaul has collaborated with scholars based in United States, Sweden and Germany. Frequent co-authors include Stephen K. Brannan, Andrew Miller, Sharon Sawchak, Haiyuan Zhu, Alan Breier, Steven M. Paul, Stephen Kanes, James Doherty, Abdul J. Sankoh and Christopher Silber. Their work appears in journals such as CNS Spectrums, Blood, The International Journal of Neuropsychopharmacology, Schizophrenia Research and The Journal of Clinical Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact